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Introduction: Hepatocyte growth factor (HGF) and hepatocyte growth factor receptor (C-MET) genes have previously
been reported to be associated with myopia in Asian family-based and case-control association studies, respectively. We
examined whether these genes were associated with myopia in a Caucasian family dataset biased towards high myopia.
Methods: Participating families had at least one offspring with high myopia (≤-5.00 diopters [D]). Genotyping was
performed with tagging single nucleotide polymorphisms (SNPs) for each candidate gene using Taqman™ allelic
discrimination assays. The data were analyzed with two family-based association methods, the pedigree disequilibrium
test (PDT) and the association in the presence of linkage (APL) test. Analyses compared 1) high myopia (<-5.00 D), 2)
mild to moderate myopia (-0.50 to -5.00 D), 3) any myopia (<-0.50 D) and 4) extreme high myopia (≤-10.00 D) versus
emmetropia using refractive error as either sphere (SPH) or spherical equivalent (SE=sphere + [cylinder/2]). Bonferroni
correction was applied to adjust for multiple testing leading to significance levels of 0.0125 for HGF and 0.008 for C-
MET. Two and three-marker sliding window haplotype association tests using APL were also performed for HGF markers.
Significance levels for haplotype association testing were set at 0.01 for the global tests, and 0.007 for the three marker
haplotype specific tests and 0.0125 for the two marker haplotype specific tests.
Results: A total of 146 multiplex families consisting of 649 Caucasian subjects were included. The HGF SNP, rs3735520
(APL  p=0.002768  for  SPH  and  0.005609  for  SE),  and  the  haplotypes,  rs2286194-rs3735520-rs17501108  (APL
p=0.007403 for SPH  and 0.062685 for SE) and  rs12536657-rs2286194 (APL  p=0.004219 for SPH and 0.00518 for
SE),  showed significant association  with mild to moderate  myopia versus emmetropia.  A  promising association
between extreme high myopia and the HGF SNP, rs2286194, was also found (APL p=0.005763 for SPH and 0.004103
for SE). No evidence of association was found in the SNPs tested for C-MET.
Conclusions: This study supports a strong association between the mild to moderate myopia group and the HGF SNP
rs3735520 and the HGF haplotypes rs2286194-rs3735520-rs17501108 and rs12536657-rs2286194, and a moderate
association of the extreme high myopia with rs2286194. C-MET polymorphism statistical associations with myopia in an
Asian study were not replicated in our Caucasian cohort. HGF may be a potential myopia candidate gene for further
investigation.
Myopia affects 33.1% of the American population greater
than 12 years of age [1], resulting in dependence on optical
correction  and/or  treatment  with  refractive  surgery.  The
estimated economic impact of correcting myopic adults in the
United States is $3.8-7.2 billion annually [2]. In addition to
financial burdens, studies have shown decreased quality of life
associated with higher levels of myopia in patients wearing
spectacle correction and/or contact lenses [3]. Patients with
pathologic  myopia  also  have  increased  risk  of  premature
cataract,  glaucoma,  retinal  detachment,  and  chorio-retinal
degeneration [4].
The mechanism underlying myopia is thought to be due
to molecular changes in the sclera via a process known as
“scleral remodeling” [4]. During this process, thinning and
Correspondence  to:  Terri  L.  Young,  M.D.,  Professor  of
Ophthalmology and Pediatrics, Duke University Center for Human
Genetics, 595 La Salle Street, Durham, NC, 27710; Phone: (919)
684-0584; FAX: (919) 684-6096; email: terri.young@duke.edu
altered  architecture  of  the  sclera  leads  to  increased  axial
elongation [4]. Scleral remodeling results from alterations in
the composition of collagen content, which is regulated by
both matrix metalloproteinases (MMP) and tissue inhibitors
of  metalloproteinases  (TIMP)  [5-10].  Hepatocyte  growth
factor (HGF) and its receptor, C-MET, modulate MMP and
TIMP pathways and therefore may play an active role in
scleral  remodeling,  axial  elongation,  and  myopia
development [11-13].
The contribution of genetic factors to the development of
myopia has been firmly established by previous studies and
has been extensively summarized in review publications [14,
15]. HGF and C-MET are two myopia candidate genes studied
in Asian populations ([16]; personal communication, Khor
C.C.,  Agency  for  Science,  Technology,  and  Research,
Singapore;  December,  2007).  Han  et  al.  [16]  performed
family-based association analysis of HGF polymorphisms (3
tagging SNPs) in a study cohort of 128 Han Chinese nuclear
families with highly myopic siblings that found association
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1028between rs3735520 (HGF5b-b) and high myopia. However,
Wang et al. [17]  were not able to replicate this association in
a recent case-control (288 cases and 208 controls) study using
the same ethnic population. In unpublished data from Khor
C.C., a case-control study found the C-MET SNP rs2073560
(MET+110703) was associated with moderate myopia in 650
Singaporean  school  children.  The  study  genotyped  and
analyzed 12 C-MET SNPs.
To date, the role of HGF and C-MET in association with
refractive  error  has  not  been  investigated  in  Caucasians.
Myopia is a complex, multi-factorial disorder. The fact that
multiple genes and environmental factors influence myopia
development  necessitates  determination  of  potential
candidate gene involvement in independent and/or diverse
datasets. Therefore, we ascertained and genotyped Caucasian
family subjects biased towards high myopia and performed
association analyses for polymorphisms and haplotypes of
HGF  and  C-MET  with  multiple  myopic  refractive  error
phenotypes.
METHODS
Subject  selection:  Approval  was  obtained  from  the
Institutional Review Boards at both participating institutions,
the Duke University Medical Center (Durham, NC) and the
Children’s  Hospital  of  Philadelphia  (Philadelphia,  PA).
Informed  consent  was  acquired  from  all  subjects  prior  to
entering the study and the principles of the Declaration of
Helsinki were followed. Families were eligible for inclusion
in the study if they had one member with spherical refractive
error of -5.00 D or more. All available family members were
recruited.  Patients  with  systemic  conditions,  syndromic
disorders,  or  ophthalmologic  conditions  which  could
predispose to high myopia were excluded. Subjects underwent
a  complete  ophthalmic  examination  including  cycloplegic
retinoscopy and/or autorefraction (Topcon RM-8800; Topcon
Medical Systems Inc., Paramus, NJ).
Marker selection and genotyping: For the candidate genes,
HGF and C-MET, the SNPSelector® program [18] was used
to choose tagging SNPs that met the criteria of a Pearson
squared  correlation  (r2)  threshold  of  0.76  in  the  linkage
disequilibrium  bins  and  a  minor  allele  frequency  (MAF)
greater than 5% in the Caucasian population. The SNPs that
Han  et  al.  [16]  and  Khor  C.C.  (Personal  communication)
reported to have significant association with myopia were
included. Sufficient tagging SNPs were selected to provide
full gene coverage. The SNPs chosen for the candidate genes
are shown in Figure 1.
Following  venous  blood  sample  collection,  genomic
DNA was extracted using AutoPure LS® DNA Extractor and
PUREGENE™ reagents (Gentra Systems Inc; Minneapolis,
MN).  For  genotyping  reactions,  custom  TaqMan®  allelic
discrimination  assays,  consisting  of  unlabeled  polymerase
chain reaction (PCR) primers and the TaqMan® minor groove
binding group (MGB) probes (FAM™ and VIC® dye-labeled;
Applied  Biosystems,  Foster  City,  CA)  were  utilized.  The
assays were comprised of 2 unlabeled PCR primers and 2
allele-specific probes. PCR reactions were performed with
Taqman® Universal PCR Master Mix on the GeneAmp® PCR
System 9700 (Applied Biosystems). The ABI7900HT Fast
PCR System (Applied Biosystems) was employed to read the
allelic discrimination calls.
For quality control (QC) purposes, two Centre d’Etude
du Polymorphisme Humain (CEPH) DNA standards were
included  in  each  96  well  plate,  and  two  blind  duplicate
samples were used per plate. Genotype submission to the
analysis  database  required  100%  matching  QC  genotypes
within  and  across  plates  and  at  least  95%  genotyping
efficiency.  All  genotypes  were  in  Hardy-Weinberg
equilibrium.  Mendelian  inconsistencies  were  checked  and
resolved.
Statistical  analyses:  Analyses  compared  the  following
myopic refractive error phenotypes: 1) high myopia (≤-5.00
D), 2) mild to moderate myopia (-0.50 to -5.00 D), 3) any
myopia (≤-0.50 D), and 4) extreme high myopia (as defined
in Han et al. [16]; ≤-10.00 D) versus emmetropia. Phenotypes
were based either on sphere (SPH) or spherical equivalent
(SE=sphere  +  [cylinder/2]).  The  family-based  pedigree
disequilibrium test (PDT) [19], genotypic PDT (genoPDT)
[20], and the association test in the presence of linkage (APL)
were performed for each myopic phenotype state [21]. The
number  of  affected  and  unaffected  subjects  for  each
classification is described in detail in Table 1. Table 2 provides
clinical information of the different myopic phenotypes.
Statistical significance for PDT, genotypic PDT and APL
tests  was  defined  as  a  p-value  ≤0.05  with  subsequent
Bonferroni correction for multiple testing (=0.05/number of
markers tested), 0.0125 for HGF and 0.008 for C-MET. Two
and three-marker sliding window for haplotype association
tests were performed using APL. For the global test statistic
generated by haplotype association testing, a p-value of ≤0.01
(0.05/number  of  haplotype  windows)  was  considered
statistically significant. Statistical significance for individual
haplotype association testing was defined as a p-value ≤0.007
for three loci (0.05/maximum number of haplotypes for each
group of loci) and ≤0.0125 for two loci.
RESULTS
The HGF results are categorized by myopic refractive error
definition in the following section. Table 3 summarizes the
APL and PDT analyses for HGF SNPs. Table 4 depicts the
APL and PDT analyses for the C-MET SNPs.
Mild to moderate myopia: On APL analysis, the risk
allele T for the HGF SNP, rs3735520, was found to have a
statistically  significant  association  with  mild  to  moderate
myopia  versus  emmetropia  (p=0.002768  for  SPH  and
0.005609 for SE). For this SNP, the p-values with PDT were
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SE). Two other HGF SNPs, rs12536657 and rs17501108, also
yielded promising associations with APL testing (p=0.043 for
both SPH and SE and p=0.032 for SPH and 0.051 for SE). The
PDT for rs12536657 (p=0.0637 for SPH and 0.0776 for SE)
and rs17501108 (p=0.2087 for SPH and 0.398 for SE) did not
reveal any statistically significant associations.
High  myopia:  APL  testing  for  the  HGF  SNP,
rs2286194, yielded a p-value that did not meet a significant
level (p=0.0396 for SPH and 0.0613 for SE) when comparing
the high myopia with emmetropia groups. For this marker, the
PDT p-values were not significant (p=0.8815 for SPH and 1
for SE). Sliding window APL analysis with the HGF markers
also did not reveal any significant haplotype associations.
Extreme high myopia: The HGF SNP, rs2286194, was
found  to  have  a  statistically  significant  association  with
extreme high myopia when compared with emmetropia by
APL testing (p=0.0058 for SPH and 0.0041 for SE). The risk
allele for rs2286194 was A. The PDT p-values for this SNP
were not significant (0.7963 for SPH and 0.7815 for SE).
There was no association identified for rs3735520 by APL
analysis (0.1734 for SPH and 0.03433 for SE) or PDT analysis
(p=0.4795 for SPH and 0.2971 for SE). None of the other HGF
SNPs  were  observed  to  have  statistically  significant
association  with  extreme  high  myopia  compared  to
emmetropia by APL or PDT analyses. Sliding window APL
analysis  with  HGF  markers  did  not  demonstrate  any
significant haplotypes for this phenotype.
Figure 1. Schematic representations of the SNPs selected for the HGF (1A) and C-MET (1B) genes (source UCSC genome browser). A total
of 4 SNPs were selected for HGF and 6 were selected for C-MET. The SNPs highlighted in yellow have previously been associated with high
myopia as reported by Han et al. [16] for HGF and Khor et al. [Personal communication, Khor CC] for C-MET. All of the SNPs are intronic
with the exception of rs3735520 which is located 1.5KB upstream from HGF and rs17501108 which is located 4.5KB upstream from HGF.
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The global test statistic for sliding window APL analysis
based on two and three marker loci yielded two significant
haplotypes: rs12536657-rs2286194 (p=0.0042 for SPH and
0.0055  for  SE)  and  rs2286194-rs3735520-rs17501108
(p=0.0074 for SPH and 0.0627 for SE). Table 5 shows the two
and three marker haplotype association results for mild to
moderate myopia. Under the significant finding with global
haplotype  testing,  the  specific  haplotype  of  G-A  for
rs12536657-rs2286194 (p=0.001499 for SPH and 0.001826
for  SE)  and  A-C-G  for  rs2286194-rs3735520-rs17501108
(p=0.006571  for  SPH)  were  determined  (Table  6).  The
haplotype  G-A  for  rs1253667-rs2286194  showed  the
strongest association for mild to moderate myopia.The global test statistic for sliding window APL analysis
based  on  two  and  three  marker  loci  found  3  significant
haplotypes:  rs12536657-rs2286194  (p=  0.009404  for  SPH
and 0.01519 for SE), rs3735520-rs17501108 (p=0.006182 for
SPH  and  0.00752  for  SE),  and  rs2286194-rs3735520-
rs17501108  (p=0.009198  for  SPH  and  0.005702  for  SE).
Similar to mild to moderate myopia, the haplotype G-A for
rs12536657-rs2286194 showed the strongest association for
any myopia (p=0.003291 for SPH and 0.004621 for SE).
Table 7 summarizes the statistically significant findings for
the mild and moderate and the any myopia groups.
DISCUSSION
The present study examined the associative involvement of
the HGF and C-MET with mild to moderate, high, and extreme
high  myopia  phenotypes  using  a  large  Caucasian  family-
based cohort biased toward high myopia. We did not find
associations between myopia and  C-MET polymorphisms,
and hence, the gene does not appear to play a role in myopia
pathogenesis  in  our  dataset.  HGF  demonstrated  the  most
promising findings with the following evidence to support its
association: (1) the significant p-values met the family-wide
significance level based on Bonferroni correction (minimum
p=0.0028  at  rs3735520);  (2)  the  association  signal  was
consistent between mild to moderate and any myopia; (3)
regardless of phenotype definition, SNPs in HGF showed
some indication of association, even though it was not always
from the same markers; and (4) the results were similar with
the different phenotype definitions, SE and SP. In addition to
these  significant  analytical  results,  HGF  is  an  excellent
biological candidate gene for myopia as it potentially plays a
role in the scleral remodeling process.
The mild to moderate myopia group showed a statistically
significant association with the HGF SNP, rs3735520. On
global  testing,  this  SNP  was  included  in  the  haplotype,
rs22861947-rs3735520-rs17501108, which had a statistically
significant association with mild to moderate myopia as well.
The specific haplotype, A-C-G, demonstrated a significant
association for this phenotype. These findings indicate that
rs3735520 may be an important SNP in the development of
mild to moderate myopia.
In  addition,  two  other  HGF  SNPs,  rs12536657  and
rs17501108, had promising associations with this phenotype.
By conducting haplotype analysis for all combinations of two
and  three  loci,  we  found  that  the  combination  including
rs12536657-rs2286194  revealed  the  most  significant
haplotype association. Although rs12536657 and rs2286194
only met a nominal significance (p≤0.05), they appeared to
act together to generate a stronger association than the single
TABLE 1. SUMMARY OF MYOPIA DEFINITIONS AND THE NUMBER OF SUBJECTS IN EACH GROUP FOR THE STUDY POPULATION.
Definition based on
myopia severity
Type of
refractive
error
Affected
(A)
Unaffected
   (N)
Unknown
   (U) Total
High-grade
myopia
A<-5.0 D
N≥-0.49 D
U=others
SPH 303 137 209 649
SE 285 155               209              649
Mild to
moderate
myopia
-4.99 D≤A≤-0.5 D
N≥-0.49 D
U=others
SPH 206 137 306 649
SE 204 155               290              649
Any myopia A<-0.5 D
N>0 D
-0.5 D<U<0 D
SPH 509 124 16 649
SE 489 131 29               649
Extreme
myopia
A≤-10.0 D
N≥-0.5 D
-10.0 D<U<-0.5 D
SPH 128 137 384 649
SE 113 155                381             649
A=affected, N=unaffected, U=unknown, D=diopters, SPH=sphere, SE=spherical equivalent.
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Phenotype
Any myopia: Promising association was found between
any myopia and rs3735520 (p=0.01714 for SPH and 0.01308
for  SE).  However,  no  individual  SNPs  were  found  to  be
statistically significant under the most conservative definition
of significance.T
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.markers alone. Therefore, in addition to rs3735520, the region
surrounding  rs12536657  and  rs2286194  may  harbor
additional important variants for this phenotype.
The association of HGF with myopia was first described
by Han et al., who defined high myopia with SE >-10.00 D.
In  their  study,  significant  association  was  found  between
rs3735520  and  high-grade  myopia.  However,  we  have
identified a different SNP association, rs2286194, which is
45,490 base pairs upstream of rs3735520, for both high and
extreme  high  myopia.  In  our  study,  rs3735520  had  a
“marginal” association with extreme high myopia, but not
high myopia.
The discrepancy between the results of the two studies
may have occurred because our study focused strictly on the
Caucasian population, whereas Han et al. [16] performed his
study in a Han Chinese population. In addition, the two studies
used different grades of myopia as inclusion criteria. Our
inclusion criteria was myopia ≤-5.00 D which resulted in a
smaller extreme high myopia sample size, while Han et al.
[16]  targeted  subjects  with  myopia  ≤-10.00  D.  Another
possible  consideration  is  that  patients  in  our  study  were
ascertained earlier in the process of developing myopia, and
may proceed to higher grades of myopia with time. Since Han
et al. [16] did not stratify their results by level of myopia as
we  did,  we  cannot  verify  the  association  evidence  for
rs3735520 in mild to moderate myopia. Due to significant
differences in study design, it is not surprising that meta-
analyses for rs3735520 and rs2286194 using Fisher’s exact
test were not significant (0.0627 and 0.0863, respectively).
It  should  be  noted  that  the  evidence  of  significant
association presented here is from the APL analysis, and PDT
did not reveal any significant results. While both PDT and
APL are robust family-based association methods, it is known
that PDT treats each discordant sibpair and parent-offspring
TABLE 5. ASSOCIATION ANALYSIS BETWEEN HAPLOTYPES PHENOTYPES.
High myopia Mild-moderate myopia Any myopia                        Extreme myopia
SPH SE                  SPH                     SE SPH                 SE SPH SE
rs12536657
rs2286194
0.6369 0.5721 0.0042
(0.021)
0.0055
(0.0275)
0.0094
(0.047)
0.0152 0.4933 0.3288
rs2286194
rs3735520
0.2958 0.2810 0.0342 0.1044 0.0358 0.0437 0.0871 0.0733
rs3735520
rs17501108
0.0800 0.0766 0.0289 0.0410 0.0062
(0.031)
0.0075
(0.0375)
0.1447 0.0481
rs12536657
rs2286194
rs3735520
0.2871 0.2844 0.0751 0.1107 0.0384 0.0345 0.3075 0.1607
rs2286194
rs3735520
rs17501108
0.1634 0.1577 0.0074
(0.037)
0.0627 0.0092
(0.046)
0.0057
(0.0285)
0.1661 0.0571
Association analysis between haplotypes and the following phenotypes using either sphere (SPH) or spherical equivalent (SE):
1) high myopia (≤-5.00 diopters [D]) 2) mild to moderate myopia (-0.50 to -5.00 D), 3) any myopia (≤-0.50 D) and 4) very high
myopia  (≤10.00  D)  versus  emmetropia.  Significant  global  haplotypes  were  obtained  by  analyzing  the  possible  allele
combinations of either two or three loci. Locus nucleotide identity and p-value are identified for each combination with a
significant p-value. Corrected p-values are in parentheses.
TABLE 6. ALLELE FREQUENCIES FOR THE HAPLOTYPES FOUND TO BE SIGNIFICANT UNDER GLOBAL TESTING FOR MILD-MODERATE MYOPIA (-0.50 TO -5.00D).
Haplotype                                                      Frequency             Observed               Expected               p value                      Corrected
p value
rs12536657 rs2286194
A A   0.1557 14 19 0.0758 0.3032
A T   0.0059 1 1 0.3025 1.21
G A   0.7309 111 101 0.0015 0.006
G T   0.1075 8 13 0.0215 0.86
rs2286194 rs3735520 rs17501108
A C G 0.3142 49 43 0.0066 0.0462
A C T 0.3952 42 48 0.0734 0.5138
A T G 0.1538 22 18 0.0753 0.5271
A T T 0.0138 2 2 0.4538 3.1766
T C T 0.1230 9 14 0.0251 0.1757
Significant p values are in bold.
Molecular Vision 2009; 15:1028-1035 <http://www.molvis.org/molvis/v15/a108> © 2009 Molecular Vision
1033
Markerstriad independently within a general pedigree, while APL
considers  identical  by  descent  from  pairs  of  siblings.
Therefore, APL is generally more robust than PDT when
multiple affected individuals per family are available. Since
our ascertainment strategy was initially targeted on linkage
study, the majority of families used in the present study have
more than two affected individuals and 8% families have more
than three generations, which is a more suitable study design
for APL than PDT tests. This may be the reason that there was
a discrepancy between the results from the two methods.
In conclusion, our study revealed an association between
rs3735520 and 2 haplotypes and mild-moderate myopia in a
predominately Caucasian population. We also detected an
association between rs2286194 and extreme high myopia. We
did  not  find  any  significant  associations  between  C-MET
polymorphisms and myopia. This represents the first analysis
of HGF and C-MET polymorphisms and myopia in a non-
Asian cohort. Our study suggests that the HGF associations
with myopia may be present in the Caucasian population, but
that genotype-phenotype relationships may differ between
various ethnic datasets in the complex disorder of myopia.
Further genetic studies in Caucasians are needed to confirm
our findings.
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